Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.04
-0.66 (-4.82%)
At close: Aug 14, 2025, 3:59 PM
13.03
-0.08%
After-hours: Aug 14, 2025, 05:54 PM EDT

Medifast Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
602.46M 1.07B 1.6B 1.53B
Cost of Revenue
157.84M 296.2M 458.16M 398.49M
Gross Profit
444.62M 775.85M 1.14B 1.13B
Operating Income
2.88M 126.4M 184.81M 216.24M
Interest Income
4.8M 2.49M n/a 231K
Pretax Income
3.79M 128.8M 184.06M 216.13M
Net Income
2.09M 99.42M 143.57M 164.03M
Selling & General & Admin
441.75M 649.45M 955.61M 911.36M
Research & Development
n/a 4.6M 4.5M 4.4M
Other Expenses
n/a n/a -46K 119K
Operating Expenses
441.75M 649.45M 955.61M 911.36M
Interest Expense
n/a n/a 701K 231K
Selling & Marketing Expenses
n/a 3.4M 1.7M 1.6M
Cost & Expenses
599.59M 945.65M 1.41B 1.31B
Income Tax Expense
1.7M 29.38M 40.49M 52.1M
Shares Outstanding (Basic)
10.93M 10.88M 11.2M 11.71M
Shares Outstanding (Diluted)
10.96M 10.92M 11.28M 11.81M
EPS (Basic)
0.19 9.13 12.82 14.01
EPS (Diluted)
0.19 9.10 12.73 13.89
EBITDA
15.59M 139.51M 201.84M 223.05M
EBIT
2.88M 126.4M 184.76M 216.24M
Depreciation & Amortization
12.71M 13.11M 17.08M 11.88M